An analysis of mortality and body mass index (BMI) data from 1971 through 2000 revealed that while being either underweight (BMI 18.5 or less) or obese (BMI 30 to 35 or greater) could endanger your life, just being overweight (BMI 25 to less than 30) did not. On the contrary, it turned out that overweight people had lower mortality rates from any cause than people who managed to maintain a so-called normal weight (BMI 18.5 to less than 25).
An analysis of mortality and body mass index (BMI) data from 1971 through 2000 revealed that while being either underweight (BMI 18.5 or less) or obese (BMI 30 to 35 or greater) could endanger your life, just being overweight (BMI 25 to less than 30) did not. On the contrary, it turned out that overweight people had lower mortality rates from any cause than people who managed to maintain a so-called normal weight (BMI 18.5 to less than 25).1
Now a refined analysis of the data enables the same researchers to be more specific about the advantages-and risks-of being overweight.2 In the new study, researchers examined cause-specific excess deaths in the year 2004 from cardiovascular disease (CVD), cancer, and all other causes, and correlated these with BMI categories. The analysis showed that
Where does all this leave the primary care practitioner, puzzling over what advice to give patients about maintaining a healthy weight? Clearly, obese patients should be counseled to lose weight, and underweight patients to try to put on a few pounds. And as for your "overweight" patients? Perhaps it's time to revise that definition.
1. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity.JAMA. 2005;293(15):1861-1867.
2. Flegal KM, Graubard BL, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007; 298(17):2028-2037.
Emerging Therapies Committee at UC Davis Hits the Accelerator Not the Brake | AMCP 2024
April 18th 2024After the onboarding of cell and gene therapy bogged using normal pharmacy and therapeutics (P&T) committee procedures, UC Davis Health set up an emerging therapeutics committee to streamline and speed up the process of delivery expensive cell and gene therapies.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
April 18th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More